MODIFICATION
66 -- Centrifuge with 4 (1-year Post-Warranty Maintenance Options) - Updated Specifications
- Notice Date
- 6/6/2013
- Notice Type
- Modification/Amendment
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA-SOL-13-1119385
- Archive Date
- 6/28/2013
- Point of Contact
- Yolanda T. Peer, Phone: 8705437479
- E-Mail Address
-
yolanda.peer@fda.hhs.gov
(yolanda.peer@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- The purpose of this Amendment is to update the Specifications that are included in the Sources Sought notice (Detailed Description of the Rotors has been included) and to extend the Response date from June 11, 2013 to June 13, 2013 MARKET RESEARCH PURPOSES ONLY NOT A REQUEST FOR PROPOSAL OR SOLICITATION The U.S. Food and Drug Administration (FDA), is conducting market research to support the Center for Biologics Evaluation and Research (CBER) requirement for a Centrifuge with four (4) 1-year Post-Warranty Maintenance Option Periods. The FDA is seeking business sources, including total small businesses, service-disabled veteran-owned small businesses, HUBZone small businesses, 8(a) certified companies and other than small businesses. In addition, the FDA is seeking business sources to determine the availability and capability of small business manufacturers or small businesses capable of supplying a U.S. made product of a small business manufacturer or producer. The associated North American Industry Classification System (NAICS) Code is- 334516 - Analytical Laboratory Instrument Manufacturing; Small Business Size Standard of 500 Employees. The following information is provided to assist the FDA in conducting Market Research to identify potential contractors for this effort: Background The Center for Biologics Evaluation and Research requires a centrifuge to perform experiments under BSL-2 containment conditions. The centrifuge is required to conduct experimentation in molecular biology, immunology, vaccine development and diagnostics of bioterrorism agents. Specifications: • RCF ≥ 100,605 x g with broad rotor portfolio supporting higher performance and continuous flow/zonal capability • Auto-Lock Rotor Exchange • Immediate identification of a rotor • Rotor specifications automatically loaded into centrifuge parameters • Fiberlite Carbon Fiber Rotors F9-6x1000 LEX Fiberlite Fixed Angle Superspeed Rotor, 6 x 1000 mL, 9,000 rpm, 17,568 x g • Swinging Bucket Rotors BIOFlex HC ("High Capacity") Stainless Steel Swinging Bucket Rotor with Aluminum Buckets, 4 x 1000 mL, 5,500 rpm, 7,068 x g • Fixed Angle Rotors A23-6x100 Aluminum Fixed Angle Superspeed Rotor, 6 x 100 mL, 23,500 rpm, 62,976 x g in the Lynx 6000 • Continuous Flow/Zonal Rotors T29-8x50 Titanium Fixed Angle Superspeed Rotor, 8 x 50 mL, 29,000 rpm, 100,605 x g • Touchscreen Interface-Simple set-up with large, bright interactive touchscreen for all functions • Integrated rotor calculator for protocol modifications and transfers • Operator run logging and reporting, optional password protection • Integrated surface workspace • Quiet performance (≤59 dBA) • Door opens fully and automatically using door open bar • Onboard run logging of user and run conditions • Max. Capacity (with Fixed Angle rotors) of at least 6 Liters • Max. Capacity (with Swinging Bucket Rotors) of at least 4L, 24 microplates, 40 x 50mL or 96 x 15mL conical tubes • Max. Speed ≥29,000rpm • Min. Speed ≤500rpm • Rotor Identification Auto-ID Instant, Automatic • Imbalance Tolerance 5% of Opposing Loads • HEPA Filter Option • Speed Control Accuracy +25rpm • Pre-Cooling Function • Temperature Set Range -20° to +40°C • Temperature Accuracy ±2°C • ACE Integrator (w2t) • Dimensions: not greater than (D x W x H) 805 x 700 x 930mm (31.7 x 27.6 x 36.6 in.) • Work height at top deck: not greater than 860mm (33.9 in.) 4 (1-year Post-Warranty Maintenance Option Periods): • On-Site Preventive Maintenance inclusive of all labor, travel, and parts, components, subassemblies, etc. • Preventive and Corrective Maintenance performed by OEM-certified technicians, following OEM specifications, manuals, and service bulletins, using OEM-certified tools and replacement parts, components, subassemblies, etc. • Unlimited On-Site Corrective Maintenance/Repairs Monday through Friday 8:00AM to 5:00PM EST within 24-48 hours. • Replacement parts and labor inclusive of all labor, travel, parts, components, subassemblies, etc • Remedial service and Engineering charges • All items utilized for repair and/or maintenance shall be new or true factory remanufactured OEM parts • Recalibrations inclusive of all labor, travel, parts, components, subassemblies, etc. • Unlimited Telephone Technical Support and Trouble Shooting Assistance 24/7 during regular business hours - Monday through Friday 8:00AM to 5:00pm EST. • Unlimited Software Updates and Firmware Updates Place of Performance: FDA/CBER 8800 Rockville Pike Bldg 29, Room 231 Bethesda, MD 20892 Responses to this sources sought shall unequivocally demonstrate that respondent is regularly engaged in the manufacture and/or sale of same or substantially similar items. Though the target audience is small business manufacturers or small businesses capable of supplying a U.S. made product of a small business manufacturer or producer all interested parties may respond. At a minimum, responses shall include the following: • Business name and bio, DUNS number, business address, business website, business size status (i.e., SB, VOSB, SDVOSB, HUBZone SB, 8(a), SDB, WOSB, EDWOSB, LB), point of contact name, mailing address (if different from business address), phone number and email address; [Provide this same information again if responding to provide a product manufactured by another firm.] • Three (3) years of past performance information for the manufacture and/or sale of same or substantially similar items to include date of sale, description (should also include drawings and photos), dollar value, client name, client address, client point of contact name, client point of contact mailing address (if different from that provided for client), client point of contact phone number, client point of contact email address, and name of the manufacturer (to include DUNS number and size status) if not the respondent; • Descriptive literature, brochures, marketing material, etc. detailing the nature of the items the responding firm is regularly engaged in manufacturing and/or selling; • If applicable, identification of the firm's GSA Schedule contract(s) by Schedule number and SINs that are applicable to this requirement; • If a large business, identify the subcontracting opportunities that would exist for small business concerns; and • Though this is not a request for quote, informational pricing is encouraged. The Government encourages any comments and/or suggestions from any interested party, regarding the specifications. While the Government will not respond directly to your comments and/or suggestions; we will consider them as we finalize the specifications in preparation for the forthcoming solicitation. The Government is not responsible for locating or securing any information, not identified in the response. Interested Parties must respond with capability statements which are due in person, by postal mail or email to the point of contact listed below on or before June 13, 2013 by 13:00 hours (Central Time in Jefferson, Arkansas) at the Food and Drug Administration, OC/OA/OAGS, Attn: Yolanda Peer, 3900 NCTR Road, HFT-320, Jefferson, AR 72079-9502 or email yolanda.peer@fda.hhs.gov. Reference FDA-SOL-13-1119385. Notice of Intent Responses to this sources sought announcement will assist the Government in determining whether or not any future requirement similar to this one should be set aside for small business, made available to full and open competition or procure through sole-source acquisition procedures. Disclaimer and Important Notes This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in FedBizOpps. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-SOL-13-1119385/listing.html)
- Place of Performance
- Address: FDA/CBER, 8800 Rockville Pike, Bldg 29, Rm 231, Bethesda, Maryland, 20892, United States
- Zip Code: 20892
- Zip Code: 20892
- Record
- SN03082690-W 20130608/130607001209-b7b6bafd40f0c50258397f167b7bf9ac (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |